Perioperative pembrolizumab in locally advanced cutaneous squamous cell carcinoma: A prospective phase 2 clinical trial
Authors:
- Hugh GallowayHGHugh Galloway
- Rodrigo X. Das NevesRNRodrigo X. Das Neves
- Florent AmatoreFAFlorent Amatore
- Arivarasan KarunamurthyAKArivarasan Karunamurthy
- Samy KottiSKSamy Kotti
- Drew HurdDHDrew Hurd
- Shaum SridharanSSShaum Sridharan
- Hong WangHong Wang
- Marion JoyMJMarion Joy
- Tanner FreemanTFTanner Freeman
- Robert M. MorrisonRMRobert M. Morrison
- Mohammed A. GhribMGMohammed A. Ghrib
Open Access
- 6 November 2026
- journal article
- Published by Elsevier in Cell Press Blue
Abstract
No abstract availableFunding Information
- Gateway Foundation
- U.S. Department of War
- National Cancer Institute
This publication has 60 references indexed in Scilit:
- Updated pan-tumor guidelines for neoadjuvant scoring of pathologic response: a joint SITC and INMC effortAnnals of Oncology, 2025
- Efficacy and safety of cosibelimab in advanced cutaneous squamous cell carcinoma: Results from a Pivotal Open-label Study with a median follow-up of ≥2 yearsJournal of the American Academy of Dermatology, 2025
- Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trialCancer Cell, 2024
- Targeted Mass Spectrometry for Quantification of Receptor Tyrosine Kinase Signaling2024
- Neoadjuvant-Intent Immunotherapy in Advanced, Resectable Cutaneous Squamous Cell CarcinomaJAMA Otolaryngology–Head & Neck Surgery, 2024
- Outcomes of Treatment With Neoadjuvant Cemiplimab for Patients With Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and NeckJAMA Otolaryngology–Head & Neck Surgery, 2023
- Pembrolizumab for locally advanced and recurrent/metastatic cutaneous squamous cell carcinoma (KEYNOTE-629 study): an open-label, nonrandomized, multicenter, phase II trialAnnals of Oncology, 2021
- Conventional type I dendritic cells maintain a reservoir of proliferative tumor-antigen specific TCF-1+ CD8+ T cells in tumor-draining lymph nodesImmunity, 2021
- Performance of the American Joint Committee on Cancer Staging Manual, 8th Edition vs the Brigham and Women’s Hospital Tumor Classification System for Cutaneous Squamous Cell CarcinomaJAMA Dermatology, 2019
- An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome AnalyticsCell, 2018